We invest exclusively in new ventures operating within the $2.6
trillion U.S. Healthcare industry. Examples of sectors in which we invest include:

  • Medical technologies
  • Healthcare services
  • Healthcare IT


We are early-stage venture investors, typically in the first or second round of institutional capital (Series A or B). We occasionally invest in the Seed round of a particularly promising technology, and we generally prefer to invest at the growth stage in healthcare service companies – that is to say, once a profitable unit economic model has been demonstrated.


We generally invest $2-6 million per round and target $4-12 million in total capital invested over the life of a company, but are flexible based on the needs of the company. We prefer to syndicate with other venture firms, are often the lead investors in a particular round and typically serve on the board of directors of our portfolio companies.


Santé maintains offices in Austin and Houston. We invest in companies headquartered in the United States.

December 27, 2018 Boston Scientific Exercises Option to Acquire Millipede, Inc. for $540M (Santé Ventures Leads Deal as Only Institutional Investor)
Read More
December 5, 2018 Iterion Therapeutics Initiates Phase I Clinical Study of Tegavivint in Patients with Desmoid Tumors
Read More